Robert Harrington to Phospholipase A2 Inhibitors
This is a "connection" page, showing publications Robert Harrington has written about Phospholipase A2 Inhibitors.
Connection Strength
0.149
-
Darapladib for preventing ischemic events in stable coronary heart disease. N Engl J Med. 2014 May 01; 370(18):1702-11.
Score: 0.115
-
Lipoprotein-Associated Phospholipase A2 Activity Is a Marker of Risk But Not a Useful Target for Treatment in Patients With Stable Coronary Heart Disease. J Am Heart Assoc. 2016 06 21; 5(6).
Score: 0.034